title: Usefulness of human papilloma virus testing in the screening of cervical cancer precursor lesions: a retrospective study in 314 cases.
abstract: OBJECTIVE
  To assess the usefulness of human papilloma virus (HPV) typing for predicting pre-malignant and malignant cervical lesions.
  
  
  METHODS
  314 women, who underwent colposcopy, biopsies and high and low-risk HPV typing after a confirmed abnormal routine Pap test were studied. HPV-DNAs were typed by using PCR technique.
  
  
  RESULTS
  We found a significant increasing rate of high-risk-HPV by the increasing severity of histology, ranging from 40% in negative cases to 86.9% in those with CIN3 lesions. The positive predictive value of high-risk-HPV ranged from 13.3% in patients with atypical squamous cells of undetermined significance (ASCUS) to 29.4% in those with HSIL. By contrast, negative predictive value was 96% in patients with ASCUS, 97.2% in low-grade squamous intraepithelial lesions (LSIL), and 71.4% in high-grade squamous intraepithelial lesions (HSIL). Sensitivity and specificity for detecting CIN2 or CIN3 was 86.0% and 41.3%, respectively.
  
  
  CONCLUSIONS
  The high negative predictive value of high-risk HPV testing suggests that HPV negativity could be used for predicting the absence of important cervical lesions, and therefore avoiding unnecessary colposcopy in ASCUS and LSIL cases.
authors.affiliation: Istituto di Oncologia Ginecologica, Università di Padova, Padova, Italy. infantolino@ulssasolo.ven.it
authors.forename: C
authors.initials: C
authors.lastname: Infantolino
authors.forename: P
authors.initials: P
authors.lastname: Fabris
authors.forename: D
authors.initials: D
authors.lastname: Infantolino
authors.forename: M R
authors.initials: MR
authors.lastname: Biasin
authors.forename: E
authors.initials: E
authors.lastname: Venza
authors.forename: G
authors.initials: G
authors.lastname: Tositti
authors.forename: D
authors.initials: D
authors.lastname: Minucci
mesh_terms: D000328:Adult; D001706:Biopsy; D003127:Colposcopy; D004279:DNA, Viral / Q000032:analysis; D005260:Female; D005838:Genotype; D006801:Humans; D008403:Mass Screening; D027383:Papillomaviridae / Q000145:classification / Q000235:genetics / Q000302:isolation & purification*; D016133:Polymerase Chain Reaction; D011230:Precancerous Conditions / Q000175:diagnosis / Q000473:pathology / Q000821:virology*; D012189:Retrospective Studies; D012307:Risk Factors; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000821:virology*; D014626:Vaginal Smears; D002578:Uterine Cervical Dysplasia / Q000175:diagnosis / Q000473:pathology / Q000821:virology
chemical_list: D004279:DNA, Viral